HC Wainwright Reaffirms “Neutral” Rating for AquaBounty Technologies (NASDAQ:AQB)

HC Wainwright restated their neutral rating on shares of AquaBounty Technologies (NASDAQ:AQB) in a research report released on Thursday morning, Benzinga reports.

Separately, Oppenheimer restated a market perform rating on shares of AquaBounty Technologies in a research report on Tuesday, April 2nd.

AquaBounty Technologies Trading Down 8.7 %

NASDAQ AQB opened at $1.82 on Thursday. AquaBounty Technologies has a 1 year low of $1.57 and a 1 year high of $10.60. The company has a debt-to-equity ratio of 0.03, a current ratio of 0.26 and a quick ratio of 0.68. The company has a market capitalization of $7.03 million, a PE ratio of -0.21 and a beta of 1.31. The company has a fifty day moving average of $1.94 and a 200 day moving average of $2.23.

AquaBounty Technologies (NASDAQ:AQB) last issued its quarterly earnings data on Wednesday, May 15th. The company reported ($1.53) earnings per share (EPS) for the quarter, missing the consensus estimate of ($1.42) by ($0.11). AquaBounty Technologies had a negative net margin of 1,263.43% and a negative return on equity of 16.07%. The company had revenue of $0.48 million during the quarter, compared to analyst estimates of $0.50 million. Research analysts forecast that AquaBounty Technologies will post -4.5 earnings per share for the current year.

About AquaBounty Technologies

AquaBounty Technologies, Inc, a biotechnology company, focuses on enhancing productivity in the commercial aquaculture industry in the United States and Canada. It engages in genetic, genomic, and fish health and nutrition research activities. The company also operates salmon farms using proprietary technology.